- Angel and venture investors have fewer secrets these days, and they were more than willing to dispense some advice to early-stage executives during the National SBIR-STTR Conference.
In evaluating MatriLab, a Milwaukee-based biotech with scientific ties to the University of Wisconsin-Madison
, they counseled technology start ups to......Full article >>>
tion of higher animal studies on pigs and further business development work.
George Arida, managing director of Venture Investors
, liked the fact that MatriLab has established milestones, which is a sign to investors that some thought has been put into the development of the company. The same "stair step" approach will benefit the company when......Full article >>>
ter returns, Meier said it's not a bad idea for any technology company to start thinking about sales long before the product goes to market. If nothing else, talking to potential future customers will sharpen the sense of product validation.
"Before you even start your business," Meier said, "you should be making sales calls."
......Full article >>>
Source:wistechnology.com By Joe Vanden Plas 11/08/06Related biology technology :1
. Early-stage quality brings investment, Meier says2
. Financial executives to launch Madison chapter3
. RoleFlow launches process-management software for executives4
. Brazilian bio-industry should impress American investors5
. Bio-energy and cleantech grab attention of investors6
. Angel investors commit $12.7B in first half of `067
. Wisconsin investors the lifeblood of New Jersey biotech8
. California investors acquire RedPrairie Corp.9
. Wisconsin investors will make their pitch to IPIC10
. Winner of Burrill competition courted by North Carolina investors11
. Platypus raises $1.2 million from private investors